Staff reviewers of the U.S. Food and Drug Administration (FDA) have raised questions about the safety of AstraZeneca Plc’s gout…
Read MoreStaff reviewers of the U.S. Food and Drug Administration (FDA) have raised questions about the safety of AstraZeneca Plc’s gout…
Read MoreEli Lilly and Co’s new Jardiance pill slashed deaths by 32 percent in a study of 7,000 patients with type…
Read MoreAn independent nonprofit organization that evaluates clinical and cost effectiveness of new medicines said announced prices for a just-approved class…
Read MoreSome nursing home facilities prescribe antibiotics more often than others, which is tied to increased health risks, even for residents…
Read MoreNeuroRx Inc said initial results of a small study show a combination of several drugs can reduce symptoms of depression…
Read MoreFor the first time in 20 years, patients suffering from the eye disease glaucoma may soon have new treatments as…
Read MoreThe U.S. Food and Drug Administration on Tuesday approved Pfizer Inc’s Ibrance, a potential new standard of care for advanced…
Read MoreThe extent of “folds” on the outer layer of the brain could give doctors a clue as to how well…
Read MoreIn January 2012, Lori Madsen, then 51, was walking through a parking lot, when she fell and skinned her arm.…
Read MoreWhen the HPV vaccine was first recommended for boys, health officials worried it would be an unusually hard sell. But…
Read More